Section Arrow
Quote
VYGR.NASDAQ
- Voyager Therapeutics
Quotes are at least 15-min delayed:2026/04/15 09:36 EDT
Regular Hours
Last
 4.04
+0.1 (+2.54%)
Day High 
4.04 
Prev. Close
3.94 
1-M High
4.55 
Volume 
17.12K 
Bid
4.03
Ask
4.05
Day Low
3.9999 
Open
4 
1-M Low
3.6501 
Market Cap 
234.82M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.91 
20-SMA 3.91 
50-SMA 3.92 
52-W High 5.55 
52-W Low 2.645 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.04/-1.09
Enterprise Value
263.48M
Balance Sheet
Book Value Per Share
3.29
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
40.37M
Operating Revenue Per Share
2.66
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
IMMPImmutep Limited0.9136+0.5988+190.22%-- 
LIMNLiminatus Pharma Inc0.193+0.0132+7.34%-- 
ALLOAllogene Therapeutics1.89-0.39-17.11%-- 
LNAILunai Bioworks Inc.0.3174-0.0214-6.32%-- 
RVMDRevolution Medicines149.89+2.88+1.96%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associatedvirus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous,or IV, dosing. Its segment is developing and commercializing genetic medicine.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.